GlassScriptPhysician profile
Heidi Pang
NPI 1790213494
$1,230.33
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.68 · 2023: $471 · 2024: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208 · Travel and Lodging: $5.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.27 |
| Travel and Lodging | $5.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $290.31 | 2023 | Arexvy, Bexsero, Shingrix |
| Astrazeneca Pharmaceuticals LP | $239.66 | 2024 | Breztri, Farxiga |
| Novo Nordisk INC | $161.79 | 2024 | Rybelsus, Ozempic |
| Phathom Pharmaceuticals, INC. | $156.65 | 2024 | Voquezna |
| Lilly USA, LLC | $147.39 | 2024 | Mounjaro, Jardiance |
| Amgen INC. | $131.12 | 2023 | Otezla, Repatha |
| Merck Sharp & Dohme LLC | $57.31 | 2022-2024 | Gardasil 9, Gardasil, Capvaxive |
| Cranial Technologies, INC | $17.39 | 2023 | Doc Band |
| Bayer Healthcare Pharmaceuticals INC. | $14.79 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.92 | 2023 | Tradjenta, Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Pang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.